Latest Alcohols Stories
The all-day "Finding Common Ground in the Gray Zones" workshop is a collaborative effort between San Francisco Health Plan, San Francisco Department of Public Health and San Francisco Community Clinic Consortium that will be held Thursday, May 2nd SAN FRANCISCO, May 2, 2013 /PRNewswire/ -- San Francisco Health Plan (SFHP), a community health plan serving over 80,000 San Francisco residents, is hosting a workshop to help doctors, nurses, pharmacists, and social workers treat chronic...
Pivotal data for investigational controlled release misoprostol vaginal insert in the U.S. accepted for presentation NEW ORLEANS, May 2, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present efficacy and safety data from its Phase 3 EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 61(st) annual clinical meeting of the American College of Obstetricians and Gynecologists in New Orleans, May 4 - 8, 2013. Studies accepted for...
Results of a pilot study suggest that a virtual patient advocate (VPA) could help influence positive changes and help women have healthier pregnancies. Developed at Boston University School of Medicine (BUSM), Boston Medical Center (BMC) and Northeastern University, "Gabby" is an innovative tool developed to deliver preconception care (PCC) to African-American women through interactive conversations online. The study results, which are published online in the American Journal of Health...
Over 1,000 chronic pain patients currently on opioids surveyed to understand and quantify the potential market opportunity for Collegium's DETERx® based product candidates CANTON, Mass., April 30, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a 1,021 patient survey, which consisted of patients with chronic pain currently on opioid...
Focus on Acute Pain and Uremic Pruritus SHELTON, Conn. and OSAKA, Japan, April 29, 2013 /PRNewswire/ -- Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. (Maruishi) today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan. CR845 is a highly selective, peptide-based, peripherally-restricted...
Naloxone, an anti-overdose medication, has recently gained attention as legislators are attempting to widen its use in light of the increased abuse of opiates across the US. Malibu, CA (PRWEB) April 26, 2013 Recent legislation has been proposed to address the issue of remedying overdoses caused by opiate drugs, according to a recent article in the Los Angeles Times. The primary anti-overdose drug in question, Naloxone, is a relatively inexpensive generic medication that was approved by...
Actavis acknowledges infringement of Purdue patents and acquires license from Purdue to sell generic versions of reformulated OxyContin starting as early as 2014 STAMFORD, Conn., April 26, 2013 /PRNewswire/ -- Purdue Pharma L.P. and Actavis, Inc. announced today that the companies have agreed to resolve the patent infringement lawsuits between them now pending in the United States District Court for the Southern District of New York concerning certain Purdue patents, including...
The manufacturing plant's production of methanol products meets rising global demands. HAMILTON, N.J., April 26, 2013 /PRNewswire-iReach/ -- Methanol Plant Available for Sale by International Process Plants The manufacturing plant's production of methanol products meets rising global demands. According to a recent study by IHS Chemical, global demand for methanol is forecast to rise dramatically in thenext ten years. China is driving most of that growth, with an expected CAGR of...
New Study Should Not Impact Dietary Habits PARK RIDGE, Ill., April 25, 2013 /PRNewswire/ -- "Cardiovascular disease is a complex and individualized condition. While it is important to understand the relationship between the nutrients found in foods we eat and how our gut processes them, this singular study does not change the decades of research supporting the important role eggs play in a healthy diet. In fact, the media has misinterpreted the research and the authors'...
MIAMI, April 22, 2013 /PRNewswire-USNewswire/ -- Fuisz Pharma today announced its intent to divest its strategic issued patent for the detection of opioid abuse (US 7,214,385 "Pharmaceutical Formulation Containing Dye"). This patent covers the use of dyes and staining agents in pharmaceutical dosage forms as a method to prevent the improper use of opioid drugs by visually demonstrating their misuse and abuse. For example, where a patient abuses a drug like oxycodone through nasal...
